Bottom Fishing

Bottom Fishing We’ve recently experienced a 10% market correction and that can feel unsettling. But keep this in mind: 10% corrections are normal, occurring about once every 12 to 18 months. In many ways, they’re healthy, helping to cool off excessive optimism and bring valuations back to more reasonable levels. The big question is, how […]
READ POST

What A Long Strange Trip It’s Been

What a Long Strange Trip It’s Been Wall Street worries are abundant these days and we suspect much of the problem is that investors have been spoiled with much higher-than-average market returns for a long time. That era may be coming to an end, which means we need to adjust our thought process. Since the […]
READ POST

Fear, Greed & the Average Investor

Fear, Greed & the Average Investor Understanding the role of fear and greed in the stock market is crucial for investors seeking to make good investment decisions. While these emotions can create opportunities, they can also lead to costly mistakes if not properly managed. Both fear and greed lead to extreme market conditions, which, in […]
READ POST

A New Lead Dog?

A New Lead Dog? It was a tumultuous week and although the S&P 500 was only down about 1% for the week and 3% from the all time closing high last week, it sure felt a lot worse. The S&P500 had broken key technical levels on Thursday and Friday was uneventful until the end of […]
READ POST

The Uncertainty Principle

The Uncertainty Principle The uncertainty principle is a fundamental concept in quantum mechanics. It states that there is a limit to the precision with which certain pairs of physical properties, such as position and momentum, can be simultaneously known. In other words, the more accurately one property is measured, the less accurately the other property […]
READ POST

The China Challenge to U.S. Biopharma

The China Challenge to U.S. Biopharma Marc Pentopoulos, of Vista Point Capital, who manages the biotech portion of the Palumbo Emerging Growth strategy, published what we think is an important report discussing the evolution of Chinese competition with the biopharma industry. Here is a summary of his comments: Chinese biotech companies have largely caught up […]
READ POST

Is the Stock Market Dead?

Is the Stock Market Dead? Navigating the private markets amid a shrinking universe of public companies   For generations, the stock market has provided a pathway to the American dream. Millions of families have saved and invested in public companies, and as those businesses have grown, they’ve purchased homes, started their own businesses, sent their […]
READ POST